Venatorx adds potential chronic hepatitis B treatment to its pipeline
March 10, 2021 at 13:36 PM EST
The antibiotics developers wants to begin human clinical testing of the new drug candidate during the second quarter of this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|